Dexcel Pharma

company

About

Dexcel Pharma is an international specialty pharmaceutical company.

  • 501 - 1000

Highlights

Details

Industries
Health Care,Manufacturing,Medical,Pharmaceutical
Founded date
Jan 1, 1968
Number Of Employee
501 - 1000
Operating Status
Active

Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, they develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that
spans more than 55 branded and generic products in over 140 dosage forms, our products are sold in the US, the UK, and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.

Investments

Number of Investments
Number of Lead Investments
2
0
Dexcel Pharma has made 2 investments. Their most recent investment was on Nov 13, 2018, when Roivant Sciences raised $200M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 13, 2018 Roivant Sciences
Private Equity(PE) $200M Biopharma
May 1, 2014 Roivant Sciences
Private Equity(PE) $93M Biopharma